Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SS Innovations International ( (SSII) ) just unveiled an update.
On March 10, 2026, SS Innovations reported unaudited results for the fourth quarter and full year 2025, highlighting a 79.1% year-over-year revenue increase in the quarter to $14.5 million and a 105.7% rise in full-year revenue to $42.5 million, driven by rapid growth in SSi Mantra system, instrument, and warranty sales. Despite net losses of $2.5 million in the quarter and $12.1 million for the year, the company improved its annual gross margin to 46.0%, cut its full-year net loss from 2024, eliminated long-term debt, expanded its installed base to 168 systems across ten countries with 7,885 cumulative surgeries, advanced telesurgery capabilities, submitted a 510(k) for U.S. clearance in December 2025, and on March 9, 2026 completed an $18.6 million private placement to support further global expansion and regulatory milestones.
The most recent analyst rating on (SSII) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on SS Innovations International stock, see the SSII Stock Forecast page.
Spark’s Take on SSII Stock
According to Spark, TipRanks’ AI Analyst, SSII is a Neutral.
The score is held down primarily by weak financial performance (ongoing losses and negative operating cash flow) and bearish technicals (below key moving averages with negative MACD). Offsetting these are notably positive corporate events and rapid revenue/installation growth, but valuation remains constrained by unprofitability and no dividend support.
To see Spark’s full report on SSII stock, click here.
More about SS Innovations International
SS Innovations International, Inc. is a medical technology company that develops innovative surgical robotic systems aimed at making robotic surgery more affordable and accessible globally. Its flagship product, the SSi Mantra surgical robotic system, targets high-growth markets such as India and underserved geographies, while the company advances regulatory pathways to enter the U.S. and European Union markets and expands applications including telesurgery and complex cardiac and pediatric procedures.
Average Trading Volume: 97,243
Technical Sentiment Signal: Sell
Current Market Cap: $906.1M
Learn more about SSII stock on TipRanks’ Stock Analysis page.